1.99
price up icon0.51%   0.01
after-market Handel nachbörslich: 1.90 -0.09 -4.52%
loading
Schlusskurs vom Vortag:
$1.98
Offen:
$2.02
24-Stunden-Volumen:
168.98K
Relative Volume:
0.55
Marktkapitalisierung:
$51.90M
Einnahmen:
$1.79M
Nettoeinkommen (Verlust:
$-70.90M
KGV:
-0.1281
EPS:
-15.54
Netto-Cashflow:
$-34.95M
1W Leistung:
+5.85%
1M Leistung:
-6.57%
6M Leistung:
-56.46%
1J Leistung:
-17.43%
1-Tages-Spanne:
Value
$1.86
$2.06
1-Wochen-Bereich:
Value
$1.82
$2.08
52-Wochen-Spanne:
Value
$1.5201
$16.94

Senti Biosciences Inc Stock (SNTI) Company Profile

Name
Firmenname
Senti Biosciences Inc
Name
Telefon
(650) 382-3281
Name
Adresse
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Name
Mitarbeiter
48
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-16
Name
Neueste SEC-Einreichungen
Name
SNTI's Discussions on Twitter

Vergleichen Sie SNTI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SNTI
Senti Biosciences Inc
1.99 49.03M 1.79M -70.90M -34.95M -15.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-06 Eingeleitet Laidlaw Buy
2022-10-07 Eingeleitet Morgan Stanley Equal-Weight

Senti Biosciences Inc Aktie (SNTI) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Senti Biosciences Inc. stockAccelerated profit realization - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Senti Biosciences Inc. stock priceAccelerated capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Senti Biosciences Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Exclusive: Senti Bio CEO Reveals Personal Journey and Strategic Vision for Gene Circuit Platform - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Senti Biosciences Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What makes Senti Biosciences Inc. stock price move sharplyPro Trader Stock Focus - Newser

Jul 21, 2025
pulisher
Jul 21, 2025

Solid Biosciences Inc. shares rise 3.29% premarket after Senti Bio's presentation at BioScience Forum. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum - The Manila Times

Jul 21, 2025
pulisher
Jul 21, 2025

Senti Bio to present logic-gated CAR-NK cell therapy at BioScience Forum - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Why Senti Biosciences Inc. stock attracts strong analyst attentionFree Step-by-Step Investment Guide - beatles.ru

Jul 21, 2025
pulisher
Jul 20, 2025

Is Senti Biosciences Inc. a good long term investmentRemarkably fast returns - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

Senti Bio Appoints Bryan Baum to Board of Directors, Aims for Growth with New Expertise. - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

Senti Biosciences Appoints Bryan Baum to Board, Enhancing Strategic Direction and Optimizing Value for Stakeholders - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

Bryan Baum Joins Senti Biosciences Board of Directors - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Sweetgreen, Inc. shares rise 3.77% intraday after Senti Biosciences, Inc. appoints Bryan Baum to its Board of Directors. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Senti Biosciences Appoints Bryan Baum to Board - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Senti Bio appoints K5 Global co-founder Bryan Baum to board of directors By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Senti Bio appoints K5 Global co-founder Bryan Baum to board of directors - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors - The Manila Times

Jul 18, 2025
pulisher
Jul 18, 2025

Is Senti Biosciences Inc. stock overhyped or has real potentialLow Risk ROI Maximization - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Senti Biosciences Inc. stock performs during market volatilityStrong Buy Recommendations - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

SNTI’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jul 14, 2025
pulisher
Jul 14, 2025

Senti Biosciences Stock Faces Decline Amid Market Challenges - timothysykes.com

Jul 14, 2025
pulisher
Jul 14, 2025

Senti Biosciences Soars 32.39% on Promising Clinical Trial Results - AInvest

Jul 14, 2025
pulisher
Jul 12, 2025

Senti Biosciences (NASDAQ:SNTI) Upgraded by Wall Street Zen to “Sell” Rating - Defense World

Jul 12, 2025
pulisher
Jul 04, 2025

Senti Biosciences (NASDAQ:SNTI) Trading Up 2.5% – Here’s What Happened - Defense World

Jul 04, 2025
pulisher
Jun 30, 2025

Senti Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Senti Bio Participates in Nasdaq Amplify Spotlight Series - TradingView

Jun 30, 2025
pulisher
Jun 30, 2025

Senti Biosciences, Inc.(NasdaqCM: SNTI) added to Russell 3000E Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 28, 2025

SNTI SEC FilingsSenti Bioscience 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 25, 2025

Is Senti Biosciences, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

Senti Bio Reveals Next-Gen Logic-Gated Cell Technology for Precision Cancer Treatment at SEED 2025 - Stock Titan

Jun 24, 2025
pulisher
Jun 19, 2025

FDA Grants Orphan Drug Designation to SENTI-202 for R/R AML - Targeted Oncology

Jun 19, 2025
pulisher
Jun 18, 2025

Senti Biosciences Inc (SNTI) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 18, 2025
pulisher
Jun 18, 2025

Senti Bio Receives US FDA Orphan Drug Designation for Potential Blood Cancer Treatment - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Senti Biosciences, Inc. Reports Progress in Phase 1 Trial of SENTI-202 for Acute Myeloid Leukemia, Receives Orphan Drug Designation - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

FDA grants orphan drug designation to Senti Bio’s AML treatment - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

FDA Backs Senti Bio Revolutionary Cancer Drug as 60% of AML Patients Face Critical Outcomes - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

Senti Biosciences Soars 7.91% on FDA Orphan Drug Designation - AInvest

Jun 18, 2025
pulisher
Jun 13, 2025

Senti Biosciences (NASDAQ:SNTI) Receives Buy Rating from Chardan Capital - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Senti Biosciences (SNTI) Rating and Price Target Updated by Chardan Capital | SNTI Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 10, 2025

Senti Biosciences Announces New Employment Inducement Grants - The Manila Times

Jun 10, 2025
pulisher
Jun 09, 2025

Gene Circuit Pioneer Senti Bio Grants $310K in Stock Options to Expand Next-Gen Therapy Team - Stock Titan

Jun 09, 2025

Finanzdaten der Senti Biosciences Inc-Aktie (SNTI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):